Yamaci, M. C. Et Al. 2025. Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.. Pharmaceuticals (Basel, Switzerland) , vol.18, no.4 .

Yamaci, M. C., Pamukcu, C., Erdemgil, Y., Atik, A. E., Keles, Z. Z. Y., & Can, Ö., (2025). Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.. Pharmaceuticals (Basel, Switzerland) , vol.18, no.4.

Yamaci, Merve Et Al. "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.," Pharmaceuticals (Basel, Switzerland) , vol.18, no.4, 2025

Yamaci, Merve C. Et Al. "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.." Pharmaceuticals (Basel, Switzerland) , vol.18, no.4, 2025

Yamaci, M. C. Et Al. (2025) . "Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.." Pharmaceuticals (Basel, Switzerland) , vol.18, no.4.

@article{article, author={Merve Celik Yamaci Et Al. }, title={Comparative Forced Degradation Study of Anticomplement C5 Biosimilar and Originator Monoclonal Antibodies.}, journal={Pharmaceuticals (Basel, Switzerland)}, year=2025}